The Potential of AI-Driven High-Content Imaging in Drug Discovery

We have authored a compelling and timely review that highlights the transformative potential of high-content imaging for discovering small molecules (SMs). SMs are crucial for advancing drug potency, selectivity, and precision, and their assessment through specialized cellular assays accelerates drug development. High-content imaging (HCI), which seamlessly integrates automated microscopy with sophisticated image analysis powered by artificial intelligence (AI), is revolutionizing cell-based assays by enabling a comprehensive evaluation of cellular parameters following drug treatment. The rich multivariate data generated by HCI from multiplexed assays unlock unprecedented insights into the cellular and subcellular effects of lead compounds, making it an indispensable tool in modern drug discovery.